Protection against neonatal respiratory viral infection via maternal treatment during pregnancy with the benign immune training agent OM-85
J.-F. Lauzon-Joset, K. T. Mincham, N. M. Scott, Y. Khandan, P. A. Stumbles, P. G. Holt, D. H. Strickland
Maternal treatment with OM-85 during pregnancy enhances neonatal resistance to respiratory viral infection by accelerating immune maturation and improving lung immune responses.
bioRxiv · Mar 2, 2021Immunology